WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$4.76
+0.06 (+1.28%)
Open$4.69
Previous Close$4.70
Day High$4.88
Day Low$4.59
52W High$5.50
52W Low$1.57
Volume—
Avg Volume467.7K
Market Cap252.78M
P/E Ratio—
EPS$-3.59
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+263.7% upside
Current
$4.76
$4.76
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.60M | 12.36M | 8.91M |
| Net Income | -27,679,279 | -32,052,690 | 2.41M |
| Profit Margin | -288.3% | -273.9% | 27.1% |
| EBITDA | -36,358,751 | -44,442,631 | 4.31M |
| Free Cash Flow | — | — | 1.46M |
| Rev Growth | -22.3% | -22.3% | +22.0% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |